Emerging Technologies to Address Placebo Response in CNS Trials
Explore how early treatment response in MDD trials predicts long-term outcomes, with insights into the impact of early improvement on signal...
Explore how early treatment response in MDD trials predicts long-term outcomes, with insights into the impact of early improvement on signal...
Explore the challenges of signal detection in schizophrenia trials, including rater calibration, placebo response, and data quality.
Discover how a novel biomarker could lead to a blood test that predicts antidepressant response in MDD patients within one week.